EMAIL THIS PAGE TO A FRIEND

Oncotarget

MMP3-mediated tumor progression is controlled transcriptionally by a novel IRF8-MMP3 interaction.


PMID 26008967

Abstract

Interferon regulatory factor-8 (IRF8), originally identified as a leukemic tumor suppressor, can also exert anti-neoplastic activities in solid tumors. We previously showed that IRF8-loss enhanced tumor growth, which was accompanied by reduced tumor-cell susceptibility to apoptosis. However, the impact of IRF8 expression on tumor growth could not be explained solely by its effects on regulating apoptotic response. Exploratory gene expression profiling further revealed an inverse relationship between IRF8 and MMP3 expression, implying additional intrinsic mechanisms by which IRF8 modulated neoplastic behavior. Although MMP3 expression was originally linked to tumor initiation, the role of MMP3 beyond this stage has remained unclear. Therefore, we hypothesized that MMP3 governed later stages of disease, including progression to metastasis, and did so through a novel IRF8-MMP3 axis. Altogether, we showed an inverse mechanistic relationship between IRF8 and MMP3 expression in tumor progression. Importantly, the growth advantage due to IRF8-loss was significantly compromised after silencing MMP3 expression. Moreover, MMP3-loss reduced spontaneous lung metastasis in an orthotopic mouse model of mammary carcinoma. MMP3 acted, in part, in a cell-intrinsic manner and served as a direct transcriptional target of IRF8. Thus, we identified a novel role of an IRF8-MMP3 axis in tumor progression, which unveils new therapeutic opportunities.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

F7367 Anti-Goat IgG (whole molecule)–FITC antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
F2016 Anti-Goat IgG (whole molecule)–FITC antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
F9012 Anti-Goat IgG (whole molecule)–FITC antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
HPA002267
Anti-IRF8 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV100841
Anti-IRF8 antibody produced in rabbit, affinity isolated antibody
HPA002531
Anti-IRF8 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2103913
Anti-IRF8 antibody produced in rabbit, affinity isolated antibody
SAB2107842
Anti-IRF8 antibody produced in rabbit, affinity isolated antibody
SAB4501892
Anti-MMP-3, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB2502113
Anti-MMP3 (C-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB4501893
Anti-MMP3 (Cleaved-Phe100) antibody produced in rabbit, affinity isolated antibody
SAB1406132
Anti-MMP3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA007875
Anti-MMP3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
RAB0367
Human MMP-3 ELISA Kit, for serum, plasma, cell culture supernatant and urine
EHU014871 MISSION® esiRNA, esiRNA targeting human MMP3 (esiRNA1)
EMU031941 MISSION® esiRNA, esiRNA targeting mouse Mmp3 (esiRNA1)
SAB5300422
Monoclonal Anti-MMP3 antibody produced in mouse, clone 4F10, purified immunoglobulin, buffered aqueous solution
SAB1402273
Monoclonal Anti-MMP3 antibody produced in mouse, clone 4C11, purified immunoglobulin, buffered aqueous solution
RAB0368
Mouse MMP-3 ELISA Kit, for serum, plasma and cell culture supernatant